Making the prevention of cancer a routine part of mainstream healthcare

Bookmark and Share
Published: 4 Dec 2015
Views: 1647
Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, United Kingdom

Prof Cuzick talks to ecancertv at the World Oncology Forum 2015 about the IBIS-I and II studies which looked at tamoxifen versus placebo and anastrazole versus placebo for postmenopausal women at high risk of breast cancer. Anastrazole was shown to be more effective, he says.

In the interview, he argues that the active prevention of breast cancer should be "much more routine", noting the way that high blood pressure and high cholesterol have been designated as medical problems in their own right rather than just contributing factors to other diseases.

He also explains why a proper exercise regime is so important in aiding both the prevention and treatment of breast cancer.